Dividend Arrowhead Pharmaceuticals, Inc.
Equities
ARWR
US04280A1007
Biotechnology & Medical Research
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 17.54 USD | +4.16% |
|
+9.01% | -6.70% |
EPS & Dividend: Arrowhead Pharmaceuticals, Inc.
| Fiscal Period: September | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|---|---|
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | -0.84 | -1.36 | -1.67 | -1.92 | -5 | 0.1917 | -3.368 | -3.095 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Reference price 2 | 43.06 | 62.43 | 33.05 | 26.87 | 19.37 | 16.84 | 16.84 | 16.84 |
| Nbr of stocks (in thousands) | 102,292 | 104,259 | 105,849 | 107,193 | 124,315 | 138,100 | - | - |
| Announcement Date | 23/11/20 | 22/11/21 | 28/11/22 | 29/11/23 | 26/11/24 | - | - | - |
1USD in Million2USD
Estimates
Upcoming events: Arrowhead Pharmaceuticals, Inc.
| 10/08/2025 | Q3 2025 Earnings Release (Projected) |
| 30/11/2025 | Q4 2025 Earnings Release (Projected) |
| 09/02/2026 | Q1 2026 Earnings Release (Projected) |
| 06/05/2026 | Q2 2026 Earnings Release (Projected) |
| Dividend Yield (N) | Dividend Yield (N+1) | P/E (N) | Price to Book (N) | EV / Sales (N) | ||
|---|---|---|---|---|---|---|
| -.--% | -.--% | 87.86x | - | 2.29x | ||
| -.--% | -.--% | 47.53x | 5.13x | 8.06x | ||
| 1.69% | 1.94% | 17.11x | 3x | 4.21x | ||
| -.--% | -.--% | -23.26x | 1.25x | 5.74x | ||
| -.--% | -.--% | -18.2x | 89.81x | 40.62x | ||
| -.--% | -.--% | -52.36x | - | - | ||
| -.--% | -.--% | 23.73x | 1.97x | 4.15x | ||
| -.--% | -.--% | 2026.06x | 13.42x | 26.15x | ||
| -.--% | -.--% | 12.7x | 1.96x | 2.42x | ||
| -.--% | -.--% | 19.23x | 4.32x | 4.61x | ||
| Average | 0.17% | 0.19% | 214.04x | 15.11x | 10.92x | |
| Weighted average by Cap. | 0.27% | 0.31% | 154.65x | 14.09x | 11.10x |
Year-on-year evolution of the Yield
Dividend / Share (DPS) - Evolution of Analysts' Estimates
Dividend / Share (DPS) - Estimates Revisions
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
Annual Profit -
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition